Employee-related Liabilities, Current of NovaBridge Biosciences from 31 Dec 2018 to 30 Jun 2025

Taxonomy & unit
us-gaap: USD and CNY
Description
Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Summary
NovaBridge Biosciences quarterly Employee-related Liabilities, Current in USD history and change rate from 31 Dec 2018 to 30 Jun 2025.
  • NovaBridge Biosciences Employee-related Liabilities, Current for the quarter ending 30 Jun 2025 was $1,313,000.
NovaBridge Biosciences quarterly Employee-related Liabilities, Current in CNY history and change rate from 31 Dec 2018 to 30 Jun 2025.
  • NovaBridge Biosciences Employee-related Liabilities, Current for the quarter ending 31 Dec 2023 was ¥48,604,000, a 12% increase year-over-year.
Source SEC data
View on sec.gov
Employee-related Liabilities, Current, Quarterly (USD)
Employee-related Liabilities, Current, YoY Quarterly Change (%)
Employee-related Liabilities, Current, Quarterly (CNY)
Employee-related Liabilities, Current, YoY Quarterly Change (%)

NovaBridge Biosciences Quarterly Employee-related Liabilities, Current (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2025 $1,313,000 30 Jun 2025 6-K 06 Oct 2025 2025 Q2
Q4 2024 $2,628,000 +$233,000 +9.7% 31 Dec 2024 6-K 06 Oct 2025 2025 Q2
Q4 2023 $2,395,000 -$3,909,000 -62% 31 Dec 2023 20-F 03 Apr 2025 2024 FY
Q4 2022 $6,304,000 -$1,938,000 -24% 31 Dec 2022 20-F 01 May 2023 2022 FY
Q2 2022 $4,122,000 30 Jun 2022 6-K 10 Nov 2022 2022 Q2
Q4 2021 $8,242,000 -$6,185,000 -43% 31 Dec 2021 20-F 29 Apr 2022 2021 FY
Q4 2020 $14,427,000 +$10,094,000 +233% 31 Dec 2020 20-F 28 Apr 2021 2020 FY
Q3 2020 $2,325,000 30 Sep 2020 6-K 05 Feb 2021 2020 Q3
Q4 2019 $4,333,000 31 Dec 2019 20-F 29 Apr 2020 2019 FY

NovaBridge Biosciences Quarterly Employee-related Liabilities, Current (CNY)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2023 ¥48,604,000 +¥5,121,000 +12% 31 Dec 2023 20-F 30 Apr 2024 2023 FY
Q4 2022 ¥43,483,000 -¥9,043,000 -17% 31 Dec 2022 20-F 30 Apr 2024 2023 FY
Q2 2022 ¥27,610,000 30 Jun 2022 6-K 10 Nov 2022 2022 Q2
Q4 2021 ¥52,526,000 -¥41,607,000 -44% 31 Dec 2021 20-F 01 May 2023 2022 FY
Q4 2020 ¥94,133,000 +¥63,967,000 +212% 31 Dec 2020 20-F 29 Apr 2022 2021 FY
Q3 2020 ¥15,783,000 30 Sep 2020 6-K 05 Feb 2021 2020 Q3
Q4 2019 ¥30,166,000 +¥11,297,000 +60% 31 Dec 2019 20-F 28 Apr 2021 2020 FY
Q4 2018 ¥18,869,000 31 Dec 2018 20-F 29 Apr 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.